Business Case

Analyzed a market entry strategy for a large, global pharmaceutical company to ensure it aligned with expected capacity and could be supported by its expected economic impact

A large international pharmaceutical company uncovered a capacity constraint as they prepared to launch a novel hemophilia product in Mexico. LSC was tasked with proposing adjustments to the market entry strategy with a goal of increasing treatment center patient capacity. The detailed analysis largely supported the existing strategy, but after completing an economic analysis looking at expected return on investment of market entry initiatives, four areas of adjustment were identified that could increase capacity to meet forecast while remaining cost-effective.